Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
***** Acces problem to record *****\

Identifieur interne : 000050 ( Pmc/Corpus ); précédent : 0000499; suivant : 0000510 ***** probable Xml problem with record *****

Links to Exploration step


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Electrochemotherapy in Breast Cancer: A Review of References</title>
<author>
<name sortKey="Schmidt, G" sort="Schmidt, G" uniqKey="Schmidt G" first="G." last="Schmidt">G. Schmidt</name>
<affiliation>
<nlm:aff id="AF797-1"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Juhasz Boss, I" sort="Juhasz Boss, I" uniqKey="Juhasz Boss I" first="I." last="Juhasz-Böss">I. Juhasz-Böss</name>
<affiliation>
<nlm:aff id="AF797-1"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Solomayer, E F" sort="Solomayer, E F" uniqKey="Solomayer E" first="E.-F." last="Solomayer">E.-F. Solomayer</name>
<affiliation>
<nlm:aff id="AF797-1"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Herr, D" sort="Herr, D" uniqKey="Herr D" first="D." last="Herr">D. Herr</name>
<affiliation>
<nlm:aff id="AF797-1"></nlm:aff>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PMC</idno>
<idno type="pmid">24976637</idno>
<idno type="pmc">4069212</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4069212</idno>
<idno type="RBID">PMC:4069212</idno>
<idno type="doi">10.1055/s-0034-1368538</idno>
<date when="2014">2014</date>
<idno type="wicri:Area/Pmc/Corpus">000050</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000050</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a" type="main">Electrochemotherapy in Breast Cancer: A Review of References</title>
<author>
<name sortKey="Schmidt, G" sort="Schmidt, G" uniqKey="Schmidt G" first="G." last="Schmidt">G. Schmidt</name>
<affiliation>
<nlm:aff id="AF797-1"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Juhasz Boss, I" sort="Juhasz Boss, I" uniqKey="Juhasz Boss I" first="I." last="Juhasz-Böss">I. Juhasz-Böss</name>
<affiliation>
<nlm:aff id="AF797-1"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Solomayer, E F" sort="Solomayer, E F" uniqKey="Solomayer E" first="E.-F." last="Solomayer">E.-F. Solomayer</name>
<affiliation>
<nlm:aff id="AF797-1"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Herr, D" sort="Herr, D" uniqKey="Herr D" first="D." last="Herr">D. Herr</name>
<affiliation>
<nlm:aff id="AF797-1"></nlm:aff>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Geburtshilfe und Frauenheilkunde</title>
<idno type="ISSN">0016-5751</idno>
<idno type="eISSN">1438-8804</idno>
<imprint>
<date when="2014">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<p>Electrochemotherapy is a new method for the local treatment of cutaneous and subcutaneous metastases. If surgery and/or radiotherapy are no longer possible, this innovative technology can be used effectively for local tumour control. The minor side effects of the therapy and the low intraoperative duration of treatment make it possible to admit patients to hospital for just a short time. Thus, the repeated use of electrochemotherapy has allowed for an increase in the rate of complete remissions. In fact, in 2013, this form of treatment, which consists of a low-dose cytostatic and electroporation, was also included in the mammary guidelines of the Working Group for Gynaecological Oncology (AGO) and the German Cancer Society (DKG). The favourable cost-benefit ratio makes this method of treatment very interesting in clinical practice and, as a result, it is already being used successfully in many German hospitals.</p>
</div>
</front>
</TEI>
<pmc article-type="research-article">
<pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Geburtshilfe Frauenheilkd</journal-id>
<journal-id journal-id-type="iso-abbrev">Geburtshilfe Frauenheilkd</journal-id>
<journal-id journal-id-type="doi">10.1055/s-00000020</journal-id>
<journal-title-group>
<journal-title>Geburtshilfe und Frauenheilkunde</journal-title>
</journal-title-group>
<issn pub-type="ppub">0016-5751</issn>
<issn pub-type="epub">1438-8804</issn>
<publisher>
<publisher-name>Georg Thieme Verlag KG</publisher-name>
<publisher-loc>Stuttgart · New York</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">24976637</article-id>
<article-id pub-id-type="pmc">4069212</article-id>
<article-id pub-id-type="doi">10.1055/s-0034-1368538</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Electrochemotherapy in Breast Cancer: A Review of References</article-title>
<trans-title-group xml:lang="de">
<trans-title>Elektrochemotherapie beim Mammakarzinom: eine Literaturübersicht</trans-title>
</trans-title-group>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Schmidt</surname>
<given-names>G.</given-names>
</name>
<xref rid="AF797-1" ref-type="aff"></xref>
<xref rid="CO-1" ref-type="author-notes"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Juhasz-Böss</surname>
<given-names>I.</given-names>
</name>
<xref rid="AF797-1" ref-type="aff"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Solomayer</surname>
<given-names>E.-F.</given-names>
</name>
<xref rid="AF797-1" ref-type="aff"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Herr</surname>
<given-names>D.</given-names>
</name>
<xref rid="AF797-1" ref-type="aff"></xref>
</contrib>
</contrib-group>
<aff id="AF797-1">
<institution>Uniklinik Homburg, Homburg</institution>
</aff>
<author-notes>
<corresp id="CO-1">
<bold>Correspondence </bold>
Dr. Gilda Schmidt
<institution>Uniklinik Homburg</institution>
<addr-line>Kirrbergerstraße100</addr-line>
<addr-line>66421 Homburg</addr-line>
<email>gilda.schmidt@uks.eu</email>
</corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>6</month>
<year>2014</year>
</pub-date>
<volume>74</volume>
<issue>6</issue>
<fpage>557</fpage>
<lpage>562</lpage>
<history>
<date date-type="received">
<day>23</day>
<month>2</month>
<year>2014</year>
</date>
<date date-type="rev-recd">
<day>24</day>
<month>3</month>
<year>2014</year>
</date>
<date date-type="accepted">
<day>25</day>
<month>4</month>
<year>2014</year>
</date>
</history>
<permissions>
<copyright-statement>© Thieme Medical Publishers</copyright-statement>
</permissions>
<abstract>
<p>Electrochemotherapy is a new method for the local treatment of cutaneous and subcutaneous metastases. If surgery and/or radiotherapy are no longer possible, this innovative technology can be used effectively for local tumour control. The minor side effects of the therapy and the low intraoperative duration of treatment make it possible to admit patients to hospital for just a short time. Thus, the repeated use of electrochemotherapy has allowed for an increase in the rate of complete remissions. In fact, in 2013, this form of treatment, which consists of a low-dose cytostatic and electroporation, was also included in the mammary guidelines of the Working Group for Gynaecological Oncology (AGO) and the German Cancer Society (DKG). The favourable cost-benefit ratio makes this method of treatment very interesting in clinical practice and, as a result, it is already being used successfully in many German hospitals.</p>
</abstract>
<trans-abstract xml:lang="de">
<sec>
<title>Zusammenfassung</title>
<p>Die Elektrochemotherapie ist eine neue Methode zur lokalen Behandlung von kutanen und subkutanen Metastasen. Sind Operation und/oder Radiatio nicht mehr möglich, so kann diese innovative Technik effektiv zur lokalen Tumorkontrolle eingesetzt werden. Die geringen Nebenwirkungen der Therapie und die geringe intraoperative Behandlungsdauer machen eine kurze Hospitalisation möglich. Durch wiederholten Einsatz der Elektrochemotherapie kann dabei die Rate an Komplettremissionen erhöht werden, sodass 2013 diese aus einem niedrig dosiertem Zytostatikum und Elektroporation bestehende Therapieform auch in die Mamma-Leitlinien der AGO/DKG aufgenommen wurde. Die günstige Kosten-Nutzen-Relation macht dieses Behandlungsverfahren in der klinischen Praxis sehr interessant, sodass es bereits erfolgreich in zahlreichen deutschen Kliniken eingesetzt wird.</p>
</sec>
</trans-abstract>
<kwd-group xml:lang="en">
<title>Key words</title>
<kwd>breast cancer</kwd>
<kwd>metastasis</kwd>
<kwd>mammary</kwd>
</kwd-group>
<kwd-group xml:lang="de">
<title>Schlüsselwörter</title>
<kwd>Mammakarzinom</kwd>
<kwd>Metastasierung</kwd>
<kwd>Mamma</kwd>
</kwd-group>
</article-meta>
</front>
</pmc>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000050  | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 000050  | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Pmc
   |étape=   Corpus
   |type=    RBID
   |clé=     
   |texte=   
}}

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024